Acute rejection Acute rejection grade 3A or more verified by biopsy · heart transplant recipients
Interleukin‐2 RA induction showed no clear difference in acute rejection Acute rejection grade 3A or more verified by biopsy compared with monoclonal antibody induction (low certainty).
1 finding from 1 review
Infection Number of participants diagnosed with infection · heart transplant recipients
Interleukin‐2 RA induction showed no clear difference in infection Number of participants diagnosed with infection compared with monoclonal antibody induction (low certainty).
1 finding from 1 review
CMV infection · heart transplant recipients
Interleukin‐2 RA induction showed no clear difference in cytomegalovirus infection Number of participants diagnosed with CMV… compared with monoclonal antibody induction (low certainty).
1 finding from 1 review
Post‐transplantation lymphoproliferative disorder Number of participants diagnosed with PTLD · heart transplant recipients
Interleukin‐2 RA induction showed no clear difference in post‐transplantation lymphoproliferative disorder Number of… compared with monoclonal antibody induction (low certainty).
1 finding from 1 review
Cancer · heart transplant recipients
Interleukin‐2 RA induction showed no clear difference in cancer Number of participants diagnosed with cancer compared with monoclonal antibody induction (low certainty).
1 finding from 1 review
Mortality Mortality at latest · heart transplant recipients
Interleukin‐2 RA showed no clear difference in mortality Mortality at latest compared with polyclonal antibody induction (low certainty).
1 finding from 1 review
Acute rejection Acute rejection grade 3A or more verified by biopsy · heart transplant recipients
Interleukin‐2 RA may leads to higher acute rejection Acute rejection grade 3A or more verified by biopsy compared with polyclonal antibody induction (low certainty).
1 finding from 1 review
Infection Number of participants diagnosed with infection · heart transplant recipients
Interleukin‐2 RA showed no clear difference in infection Number of participants diagnosed with infection compared with polyclonal antibody induction (low certainty).
1 finding from 1 review
CMV infection · heart transplant recipients
Interleukin‐2 RA showed no clear difference in cytomegalovirus infection Number of participants diagnosed with CMV… compared with polyclonal antibody induction (low certainty).
1 finding from 1 review
Post‐transplantation lymphoproliferative disorder Number of participants diagnosed with PTLD · heart transplant recipients
1 finding from 1 review
Cancer · heart transplant recipients
Interleukin‐2 RA showed no clear difference in cancer Number of participants diagnosed with cancer compared with polyclonal antibody induction (low certainty).
1 finding from 1 review
Intervention not reported
Mortality Mortality at latest · heart transplant recipients
The intervention showed no clear difference in mortality Mortality at latest (low certainty).
1 finding from 1 review
CMV infection · heart transplant recipients
Interleukin‐2 RA showed no clear difference in cytomegalovirus infection Number of participants diagnosed with CMV… compared with no induction (low certainty).
1 finding from 1 review
Post‐transplantation lymphoproliferative disorder Number of participants diagnosed with PTLD · heart transplant recipients
Interleukin‐2 RA showed no clear difference in post‐transplantation lymphoproliferative disorder Number of… compared with no induction (low certainty).
1 finding from 1 review
Cancer · heart transplant recipients
Interleukin‐2 RA showed no clear difference in cancer Number of participants diagnosed with cancer compared with no induction (low certainty).
1 finding from 1 review
Intervention not reported
Acute rejection Acute rejection grade 3A or more verified by biopsy · heart transplant recipients
The intervention showed no clear difference in acute rejection Acute rejection grade 3A or more verified by biopsy (low certainty).
1 finding from 1 review
Intervention not reported
Infection Number of participants diagnosed with infection · heart transplant recipients
The intervention showed no clear difference in infection Number of participants diagnosed with infection (low certainty).
1 finding from 1 review
Intervention not reported
Cytomegalovirus infection Number of patients diagnosed with CMV infection · heart transplant recipients
The intervention showed no clear difference in cytomegalovirus infection Number of patients diagnosed with CMV… (low certainty).
1 finding from 1 review
Intervention not reported
Post‐transplantation lymphoproliferative disorder Number of participants diagnosed with PTLD · heart transplant recipients
The intervention showed no clear difference in post‐transplantation lymphoproliferative disorder Number of… (low certainty).
1 finding from 1 review
Intervention not reported
Cancer Number of participants diagnosed with cancer · heart transplant recipients
The intervention showed no clear difference in cancer Number of participants diagnosed with cancer (low certainty).
1 finding from 1 review